The DOI matches its Crossref record; 57 of the 71 references it cites were found in a registry or an index.
DNA damage induces phosphorylation of the amino terminus of p53
Open accessAbstract
Data are presented demonstrating that DNA damage leads to specific post-translational modifications of p53 protein. Using two-dimensional peptide mapping of in vivo radiolabeled p53 tryptic phosphopeptides, recombinant truncated p53 protein, and synthetic p53 tryptic peptides, a unique p53 phosphopeptide was identified after exposure of ML-1 cells to ionizing irradiation. This peptide represents the first 24 amino acids of p53 and contains three phosphorylated serine residues. A specific p53 phosphopeptide antibody identified serine-15 as one of the two serines in p53 that becomes phosphorylated following DNA damage induced by either ionizing irradiation (IR) or ultraviolet (UV) irradiation in multiple cell types. IR-induced phosphorylation of p53 does not affect the kinetics of p53 binding to or dissociating from DNA as assessed by electrophoretic mobility-shift assays. However, p53 phosphorylation induced by DNA damage correlates with enhanced transcription of downstream p53 target genes. Low levels of phosphoserine-15 p53 are detectable within 6 hr after IR in AT cells, whereas lymphoblasts from normal individuals exhibit this modification within 1 hr. In contrast, phosphorylation of p53 on serine-15 is similar in normal and AT cells after UV irradiation. Our results indicate that p53 is phosphorylated in response to DNA damage, that this de novo phosphorylation may be involved in the subsequent induction and activation of p53, and that although ATM affects the kinetics of p53 phosphorylation after IR, it is not absolutely required for phosphorylation of p53 on serine-15.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Siliciano et al. 1997
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“It has been demonstrated recently that the mechanism for this inhibition involves binding Mdm2 to p53 and targeting p53 for rapid degradation (Haupt et al. 1997; Kubbutat et al. 1997).”
BackgroundDérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citationA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Self-citationp53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Cited by
Sorted by citations
Items 501–600 of 815
Lu, H., Meng, L., Huang, M., Zhu, H., Miao, Z., & Ding, J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0877-z · Cited by 27
Yarosh, D. B., Bizios, N., Kibitel, J. T., Goodtzova, K., Both, D., Goldfarb, S. B., Green, B., Brown, D., Cruz, P. D., & Dougherty, I. I. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00964.x · Cited by 27
Zeng, X., Keller, D., Wu, L., & Lu, H. (2000) · PubMed · Cited by 26
Transcription factors and cognate signalling cascades in the regulation of autophagy
Chandra, V., Bhagyaraj, E., Parkesh, R., & Gupta, P. (2016) · Biological Reviews · doi:10.1111/brv.12177 · Cited by 26
mdm-2 gene amplification in 3T3-L1 preadipocytes
Berberich, S. J., Litteral, V., Mayo, L. D., Tabesh, D., & Morris, D. (1999) · Differentiation · doi:10.1046/j.1432-0436.1999.6440205.x · Cited by 27
Lee, J.-H., Jin, Y., He, G., Zeng, S. X., Wang, Y. V., Wahl, G. M., & Lu, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336875 · Cited by 25
Yatagai, N., Saito, T., Akazawa, Y., Hayashi, T., Yanai, Y., Tsuyama, S., Ueyama, H., Murakami, T., Watanabe, S., Nagahara, A., et al. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2508-9 · Cited by 26
Integration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 27
de Feudis, P., Vignati, S., Rossi, C., Mincioni, T., Giavazzi, R., D’Incalci, M., & Broggini, M. (2000) · Neoplasia · doi:10.1038/sj.neo.7900086 · Cited by 26
Zhang, L., Jia, G., Li, W.-M., Guo, R., Cui, J., Yang, L., & Lu, Y. (2003) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2003.09.012 · Cited by 25
Esteras, N., Alquézar, C., Bermejo-Pareja, F., Bialopiotrowicz, E., Wojda, U., & Martín-Requero, Á. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.014 · Cited by 25
Sirbu, B. M., Lachmayer, S. J., Wülfing, V., Marten, L. M., Clarkson, K. E., Lee, L. W., Gheorghiu, L., Zou, L., Powell, S. N., Dahm‐Daphi, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023053 · Cited by 26
Kim, H.-T., Tasca, S. I., Qiang, W., Wong, P. K. Y., & Stoica, G. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000017373.82871.45 · Cited by 25
Regulation of p53 after Different Forms of Stress and at Different Cell Cycle StagesPreprint
Gottifredi, V., Shieh, S.-Y., & Prives, C. L. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.483 · Cited by 25
Differential role of RB in response to UV and IR damage
Bosco, E. E. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki283 · Cited by 24
ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response
Icli, B., Bharti, A. K., Pentassuglia, L., Peng, X., & Sawyer, D. B. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.144 · Cited by 24
Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas
Adamkov, M., Halášová, E., Rajčáni, J., Bencat, M., Výbohová, D., Rybárová, S., & Galbavy, S. (2011) · Medical Science Monitor · doi:10.12659/msm.881442 · Cited by 24
Replication stress: Driver and therapeutic target in genomically instable cancers
Schoonen, P. M., Llobet, S. G., & van Vugt, M. A. T. M. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.10.006 · Cited by 26
Gurung, S. K., Dana, S., Mandal, K., Mukhopadhyay, P., & Mondal, N. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.010 · Cited by 26
Oxidative stress enhances phosphorylation of p53 in neonatal rat cardiomyocytes
Long, X., Goldenthal, M. J., & Marı́n-Garcı́a, J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9470-1 · Cited by 24
Effects of ginsenoside Rg2 on the ultraviolet B-induced DNA damage responses in HaCaT cells
Ha, S. E., Shin, D. H., Kim, H. D., Shim, S. M., Kim, H. S., Kim, B., Lee, J. S., & Park, J. K. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0522-9 · Cited by 24
The DNA damage response during an unperturbed S-phase
Ben‐Yehoyada, M., Gautier, J., & Dupré, A. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.005 · Cited by 25
Minter, L. M., Dickinson, E. S., Naber, S. P., & Jerry, D. J. (2002) · Development · doi:10.1242/dev.129.12.2997 · Cited by 20
Loss of the ubiquitin conjugating enzyme UBE2E3 induces cellular senescence
Plafker, K. S., Zyla, K., Berry, W. L., & Plafker, S. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.05.008 · Cited by 24
Datta, A., & Nicot, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210718 · Cited by 23
A novel oncoprotein Pirh2: rising from the shadow of MDM2
Wang, Z., Yang, B. R., Dong, L., Peng, B., He, X., & Liu, W. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01899.x · Cited by 24
Sakai, H., Fujigaki, H., Mazur, S. J., & Appella, E. (2014) · Cell Cycle · doi:10.4161/cc.27920 · Cited by 24
Self-citationLaurent, A., & Blasi, F. (2015) · Development · doi:10.1242/dev.125708 · Cited by 22
Flavopereirine Suppresses the Growth of Colorectal Cancer Cells through P53 Signaling Dependence
Li, J., Huang, Y., Kuo, Y.-H., Cheng, C., Kuan, F., Chang, S., Lee, Y., Chin, C., & Shi, C. (2019) · Cancers · doi:10.3390/cancers11071034 · Cited by 24
Induction and Bypass of p53 during Productive Infection by Polyomavirus
Dey, D. C., Dahl, J., Cho, S., & Benjamin, T. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9526-9532.2002 · Cited by 23
Wang, Y., Compton, C., Rankin, G. O., Cutler, S. J., Rojanasakul, Y., Tu, Y., & Chen, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3894 · Cited by 22
Ramaiah, M. J., Pushpavalli, S. N. C. V. L., Lavanya, A., Bhadra, K., Haritha, V., Patel, N., Tamboli, J. R., Kamal, Ä., Bhadra, U., & Pal‐Bhadra, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.018 · Cited by 23
Acute kidney injury induces dramatic p21 upregulation via a novel, glucocorticoid-activated, pathway
Zager, R. A., & Johnson, A. C. M. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00571.2018 · Cited by 22
Reichrath, J., & Reichrath, S. (2013) · Dermato-Endocrinology · doi:10.4161/derm.24156 · Cited by 22
c-abl is involved in the association of p53 and trk A
Brown, A., Browes, C., Mitchell, M., & Montano, X. (2000) · Oncogene · doi:10.1038/sj.onc.1203619 · Cited by 21
SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression
Jaiswal, A. S., & Narayan, S. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00296-2 · Cited by 22
Regulating the genome surveillance system: miRNAs and the p53 super family
Bailey, S. G., Sánchez-Elsner, T., Stephanou, A., Cragg, M. S., & Townsend, P. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0456-1 · Cited by 22
Gadd45b deficiency promotes premature senescence and skin aging
Magimaidas, A., Madireddi, P., Maifrede, S., Mukherjee, K., Hoffman‐Liebermann, B., & Liebermann, D. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8854 · Cited by 21
Cell specific stress responses of cadmium-induced cytotoxicity
Ravindran, G., Chakrabarty, D., & Sarkar, A. (2016) · Animal Cells and Systems · doi:10.1080/19768354.2016.1267041 · Cited by 21
Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway
Choi, W., Cogdell, D. E., Feng, Y., Hamilton, S. R., & Zhang, W. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.11.3271 · Cited by 23
The role of the p53 molecule in cancer therapies with radiation and/or hyperthermia.
Ohnishi, T. (2005) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.19594 · Cited by 21
Ghosh, J. C., Izumida, Y., Suzuki, K., Kodama, S., & Watanabe, M. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0305:ddbaot]2.0.co;2 · Cited by 21
Influence of Hypoxia on Radiosensitization of Cancer Cells by 5-Bromo-2′-deoxyuridine
Zdrowowicz, M., Spisz, P., Hać, A., Herman-Antosiewicz, A., & Rak, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031429 · Cited by 20
Liang, L., Mendonca, M. S., Deng, L., Nguyen, S. C., Shao, C., & Tischfield, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1476 · Cited by 20
p53 and mitogen-activated protein kinase pathway protein profiles in fresh and frozen spermatozoa
Karabulut, S., Demiroglu‐Zergeroglu, A., Yilmaz, E. S., Sağır, F., & Delikara, N. (2013) · Andrologia · doi:10.1111/and.12200 · Cited by 20
Mithramycin selectively attenuates DNA-damage-induced neuronal cell death
Makarevich, O. D., Sabirzhanov, B. E., Aubrecht, T. G., Glaser, E. P., Polster, B. M., Henry, R. J., Faden, A. I., & Stoica, B. A. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02774-6 · Cited by 19
Chan, J. M., Ho, S. H. Y., & Tai, I. T. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq034 · Cited by 20
Tatewaki, N., Konishi, T., Nakajima, Y., Nishida, M., Saito, M., Eitsuka, T., Sakamaki, T., Ikekawa, N., & Nishida, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147570 · Cited by 21
The p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20
Warenius, H. M., Jones, M., Gorman, T., McLeish, R., Seabra, L., Barraclough, R., & Rudland, P. S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1409 · Cited by 20
Hirai, Y., Hayashi, T., Kubo, Y., Hoki, Y., Arita, I., Tatsumi, K., & Seyama, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01152.x · Cited by 20
Abraham, J., Spaner, D., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202454 · Cited by 20
Ghosh, J. C., Suzuki, K., Kodama, S., & Watanabe, M. (1999) · Journal of Radiation Research · doi:10.1269/jrr.40.23 · Cited by 20
Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice
Li, S., Ezhevsky, S. A., Dewing, A., Cato, M. H., Scortegagna, M., Bhoumik, A., Breitwieser, W., Braddock, D. T., Eroshkin, A. M., Qi, J., et al. (2010) · Genes & Cancer · doi:10.1177/1947601910370700 · Cited by 19
Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine
Henrich, S., & Christopherson, R. I. (2007) · Leukemia · doi:10.1038/sj.leu.2404929 · Cited by 19
Ozaki, T., Nakamura, M., & Shimozato, O. (2015) · Biomolecules · doi:10.3390/biom5042854 · Cited by 18
Wittlinger, M., Grabenbauer, G. G., Sprung, C. N., Sauer, R., & Distel, L. V. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701275432 · Cited by 19
Kato, S., Shimada, A., Osada, M., Ikawa, S., Obinata, M., Nakagawara, A., Kanamaru, R., & Ishioka, C. (1999) · PubMed · Cited by 19
Adenovirus‐mediated p53AIP1 gene transfer as a new strategy for treatment of p53‐resistant tumors
Yoshida, K., Monden, M., Nakamura, Y., & Arakawa, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03176.x · Cited by 19
Phosphorylation and nuclear accumulation are distinct events contributing to the activation of p53
O’Hagan, H. M., & Ljungman, M. E. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.10.003 · Cited by 19
Kong, X., Valentine, V. A., Rowe, S. T., Valentine, M. B., Ragsdale, S. T., Jones, B. G., Wilkinson, D. A., Brodeur, G. M., Cohn, S. L., & Look, A. T. (1999) · Neoplasia · doi:10.1038/sj.neo.7900010 · Cited by 19
Babu, S., Takeuchi, Y., & Masai, I. (2022) · eLife · doi:10.7554/elife.74611 · Cited by 17
The Radiomimetic Enediyne C-1027 Induces Unusual DNA Damage Responses to Double-Strand Breaks
Kennedy, D. R., & Beerman, T. A. (2006) · Biochemistry · doi:10.1021/bi052334c · Cited by 19
Borsos, B. N., Huliák, I., Majoros, H., Újfaludi, Z., Gyenis, Á., Pukler, P., Boros, I., & Pankotai, T. (2017) · Scientific Reports · doi:10.1038/srep40960 · Cited by 17
PI3K-Related Kinases: Roles in Cell-Cycle Regulation and DNA Damage Responses
Tibbetts, R. S., & Abraham, R. T. (2003) · Humana Press eBooks · doi:10.1385/1-59259-218-x:267 · Cited by 18
The diversity of p53 mutations among human brain tumors and their functional consequences
Żupańska, A. K., & Kaminska, B. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00114-0 · Cited by 18
Tickets for p53 journey among organelles
Ferecatu, I. (2009) · Frontiers in bioscience · doi:10.2741/3524 · Cited by 19
Suzuki, K., Inageda, K., Nishitai, G., & Matsuoka, M. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.028 · Cited by 18
RAPID RADIATION-INDUCTION OF ATM PROTEIN LEVELS IN SITU
Fang, Z. M., Lee, C. S., Sarris, M., Kearsley, J. H., Murrell, D., Lavin, M. F., Keating, K., & Clarke, R. A. (2001) · Pathology · doi:10.1080/00313020120034876 · Cited by 18
Datta, N. S., & Long, M. W. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00780-9 · Cited by 18
Camptothecin and Zeocin Can Increase p53 Levels during All Cell Cycle Stages
Houser, S., Koshlatyi, S., Lu, T., Gopen, T., & Bargonetti, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6073 · Cited by 18
Chk2 Phosphorylation of Survivin-ΔEx3 Contributes to a DNA Damage–Sensing Checkpoint in Cancer
Lopergolo, A., Tavecchio, M., Lisanti, S., Ghosh, J. C., Dohi, T., Faversani, A., Vaira, V., Bòsari, S., Tanigawa, N., Delia, D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4035 · Cited by 17
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells
Singh, N., Bhakuni, R., Chhabria, D., & Kirubakaran, S. (2020) · BMC Research Notes · doi:10.1186/s13104-020-04996-5 · Cited by 17
Proteasome-Dependent Downregulation of p21 Waf1/Cip1 Induced by Reactive Oxygen Species
Xie, S., Wang, Q., Luo, L., Ruan, Q., Liu, T., Jhanwar‐Uniyal, M., Darżynkiewicz, Z., Traganos, F., & Dai, W. H. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260286669 · Cited by 17
ATM activity in T cells is critical for immune surveillance of lymphoma in vivo
Riabinska, A., Lehrmann, D., Jachimowicz, R. D., Knittel, G., Fritz, C., Schmitt, A., Geyer, A., Heneweer, C., Wittersheim, M., Frenzel, L. P., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0618-2 · Cited by 17
Kwon, O., Kim, K., He, L., Kim, S. O., Kim, M. S., Cha, E. Y., Yoon, B. D., Sok, D. E., Jung, M., Ahn, J. S., et al. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.022 · Cited by 17
p53 as the main traffic controller of the cell signaling network
Sebastian, S. (2010) · Frontiers in bioscience · doi:10.2741/3669 · Cited by 16
Ren, L., Liu, Y., Guo, L., Wang, H., Ma, L., Zeng, M., Shao, X., Yang, C., Tang, Y., Wang, L., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.072 · Cited by 15
Zhou, Y., Wei, L., Zhang, H., Dai, Q., Li, Z., Yu, B., Guo, Q., & Lu, N. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25118 · Cited by 17
RetractedHublarová, P., Greplová, K., Holčáková, J., Vojtěšek, B., & Hrstka, R. (2010) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-010-0021-5 · Cited by 15
Differential regulation of survivin by p53 contributes to cell cycle dependent apoptosis
Jin, Y., Wei, Y., Xiong, L., Yang, Y., & Wu, J. R. (2005) · Cell Research · doi:10.1038/sj.cr.7290303 · Cited by 16
The Modulation of the Cell-Cycle: A Sentinel to Alert the NK Cells of Dangers
Baychelier, F., & Vieillard, V. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00325 · Cited by 16
Cortés, M. L., Bakkenist, C. J., Maria, M. V. D., Kastan, M. B., & Breakefield, X. O. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301996 · Cited by 16
Self-citationBalmer, M. T., Katz, R. D., Liao, S., Goodwine, J. S., & Gal, S. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29112 · Cited by 16
Minemoto, Y., Gannon, J., Masutani, M., Nakagama, H., Sasagawa, T., Inoue, M., Masamune, Y., & Yamashita, K. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5072 · Cited by 17
Ceruti, J. M., Scassa, M. É., Marazita, M. C., Carcagno, A. L., Sirkin, P. F., & Cánepa, E. T. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.005 · Cited by 15
Makovski, A., Yaffe, E., Shpungin, S., & Nir, U. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.004 · Cited by 15
Phosphorylation of p53 Serine 18 Upregulates Apoptosis to Suppress Myc-Induced Tumorigenesis
Sluss, H. K., Gannon, H., Coles, A. H., Shen, Q., Eischen, C. M., & Jones, S. N. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0324 · Cited by 16
Najjar, I., Schischmanoff, P. O., Baran‐Marszak, F., Deglesne, P., Youlyouz‐Marfak, I., Pampin, M., Feuillard, J., Bornkamm, G. W., Chelbi‐Alix, M. K., & Fagard, R. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0508287 · Cited by 15
Cao, Z.-G., Xu, X., Xue, Y., & Zhao, S. (2014) · Współczesna Onkologia · doi:10.5114/wo.2014.40456 · Cited by 15
Kogaki, T., Ohshio, I., Kawaguchi, M., Kimoto, M., Kitae, K., Hase, H., Ueda, Y., Jingushi, K., & Tsujikawa, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.024 · Cited by 15
Kumar, S., Tomar, M. S., & Acharya, A. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.974042 · Cited by 15
ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines
Ehrenfeld, V., Heusel, J. R., Fulda, S., & van Wijk, S. J. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244060 · Cited by 14
A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
Tang, H.-J., Qian, D., Sondak, V. K., Stachura, S. V., & Lin, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601653 · Cited by 15
Lin, J., Jin, X., Page, C., Sondak, V. K., Jiang, G., & Reynolds, R. K. (2000) · PubMed · Cited by 15
Disrupting the p53-mdm2 interaction as a potential therapeutic modality
Moll, U. M., & Zaika, A. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0160 · Cited by 15
Effect of pH on radiation-induced p53 expression
Choi, E. K., Roberts, K. P., Griffin, R. J., Han, T.-H., Park, H.-J., Song, C. W., & Park, H. J. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.04.043 · Cited by 16
Solyakov, L. S., Sayan, E., Riley, J., Pointon, A., & Tobin, A. B. (2009) · Oncogene · doi:10.1038/onc.2009.225 · Cited by 14
Comparative assessment of the functional p53 status in glioma cells.
Kim, E. L., Yoshizato, K., Kluwe, L., Meissner, H., Warnecke, G., Zapf, S., Westphal, M., Deppert, W., & Giese, A. (2005) · PubMed · Cited by 14
Lee, H., Zhu, X., Zhu, X., Skidmore, S. C., Perry, G. L., Sayre, L. M., Smith, M. A., & Lee, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05883.x · Cited by 14
Metadata
- Authors
- Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B.
- Affiliations
- National Institutes of Health (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1997-12-15
- Volume
- 11
- Issue
- 24
- Pages
- 3471-3481
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316806
- OpenAlex
- W2149013144
- Cited by
- 818
- References
- 71
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 14 · 2018: 12 · 2017: 18 · 2016: 22 · 2015: 17 · 2014: 24 · 2013: 21 · 2012: 27
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- American Society of Hematology
- National Institutes of Health (ES05777)
- National Cancer Institute (CA71387, R01CA071387)
- National Institute of Environmental Health Sciences (R01ES005777, R37ES005777, ES05777)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p53, DNA damage response, ionizing radiation, UV irradiation, post-translational modification, ATM kinase, lymphoblasts
- MeSH terms
- Ataxia Telangiectasia, Binding Sites, Cells, Cultured, DNA, DNA Damage, Electrophoresis, Humans, Lymphocytes, Nuclear Proteins, Peptide Fragments, Phosphorylation, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Serine, Ultraviolet Rays, Signal Transduction, Tumor Suppressor Protein p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review